Torre L A, Trabert B, DeSantis C E, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin, 2018,68(4):284-296.
 Colombo N, Sessa C, du Bois A, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol, 2019,30(5):672-705.
 Coleman R L, Monk B J, Sood A K, et al. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol, 2013,10(4):211-224.
 Beral V, Gaitskell K, Hermon C, et al. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet, 2015,385(9980):1835-1842.
 Peres L C, Cushing-Haugen K L, Köbel M, et al. Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst, 2019,111(1):60-68.
 Tseng J H, Cowan R A, Zhou Q, et al. Continuous improvement in primary debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?. Gynecol Oncol, 2018,151(1):24-31.
 Okamoto A, Glasspool R M, Mabuchi S, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer, 2014,24(9 Suppl 3):S20-S25.
 Huang Y, Ming X, Li B, et al. Histological characteristics and early-stage diagnosis are associated with better survival in young patients with epithelial ovarian cancer: a retrospective analysis Based on Surveillance Epidemiology and End Results Database. Front Oncol, 2020,10:595789.
 Prendergast E N, Holzapfel M, Mueller J J, et al. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort. Gynecol Oncol, 2017,144(2):274-278.
 Lee H Y, Hong J H, Byun J H, et al. Clinical characteristics of clear cell ovarian cancer: a retrospective multicenter experience of 308 patients in South Korea. Cancer Res Treat, 2020,52(1):277-283.
 Samartzis E P, Noske A, Dedes K J, et al. ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci, 2013,14(9):18824-18849.
 Hogen L, Brar H, Covens A, et al. Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?. Gynecol Oncol, 2017,147(1):54-60.
 Wentzensen N, Poole E M, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J Clin Oncol, 2016,34(24):2888-2898.
 Nasioudis D, Mastroyannis S A, Albright B B, et al. Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes. Gynecol Oncol, 2018,150(1):14-18.
 Shimizu D, Sato N, Sato T, et al. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture. J Obstet Gynaecol Res, 2015,41(3):432-439.
 Bogani G, Ditto A, Lopez S, et al. Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: A systematic review and meta-analysis. Gynecol Oncol, 2020,157(1):293-298.
 Takano M, Sugiyama T, Yaegashi N, et al. Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan clear cell carcinoma Study. Int J Gynecol Cancer, 2010,20(9):1506-1510.
 Del C M, Birrer M, Schorge J O. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol, 2012,126(3):481-490.
 Armstrong D K, Alvarez R D, Bakkum-Gamez J N, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2021,19(2):191-226.
 Suzuki K, Takakura S, Saito M, et al. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary. Int J Gynecol Cancer, 2014,24(7):1181-1189.
 Yamazaki H, Todo Y, Shimada C, et al. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma. J Gynecol Oncol, 2018,29(2):e19.
 Hirose S, Tanabe H, Nagayoshi Y, et al. Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer. J Gynecol Oncol, 2018,29(3):e37.
 Takano M, Sugiyama T, Yaegashi N, et al. The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study. Int J Gynecol Cancer, 2009,19(8):1353-1357.
 Tokunaga H, Mikami M, Nagase S, et al. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. J Gynecol Oncol, 2021,32(2):e49.
 Magazzino F, Katsaros D, Ottaiano A, et al. Surgical and medical treatment of clear cell ovarian cancer: results from the multicenter Italian Trials in Ovarian Cancer (MITO) 9 retrospective study. Int J Gynecol Cancer, 2011,21(6):1063-1070.